Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AMRN – Amarin Corp ADR

Amarin Corporation plc
AMRN
$12.72
Name : Amarin Corporation plc
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $263,393,040.00
EPSttm : -4.4
finviz dynamic chart for AMRN
Amarin Corporation plc
$12.72
7.34%
$0.87

Float Short %

2.71

Margin Of Safety %

Put/Call OI Ratio

0.09

EPS Next Q Diff

-0.66

EPS Last/This Y

1.99

EPS This/Next Y

1.95

Price

12.73

Target Price

8

Analyst Recom

4.33

Performance Q

20

Relative Volume

1.42

Beta

0.72

Ticker: AMRN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-08AMRN10.720.080.1215906
2025-05-09AMRN10.360.080.0216175
2025-05-12AMRN10.450.088.5516331
2025-05-13AMRN10.290.076.0016241
2025-05-14AMRN10.160.071.5616272
2025-05-15AMRN10.540.071.0816299
2025-05-16AMRN10.580.070.0916355
2025-05-19AMRN10.90.070.3814784
2025-05-20AMRN11.150.070.1614946
2025-05-21AMRN10.970.072.8715113
2025-05-22AMRN110.080.0015237
2025-05-23AMRN11.220.080.2915277
2025-05-27AMRN11.380.080.2415369
2025-05-28AMRN11.290.080.3515593
2025-05-29AMRN11.720.090.5215896
2025-05-30AMRN11.640.090.0816037
2025-06-02AMRN11.780.090.2416072
2025-06-03AMRN120.090.2616096
2025-06-04AMRN11.810.090.1716139
2025-06-05AMRN11.790.090.0216179
2025-06-06AMRN12.760.090.0516235
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-08AMRN10.72-100.0- -3.20
2025-05-09AMRN10.40-100.0- -3.20
2025-05-12AMRN10.42-100.0- -3.20
2025-05-13AMRN10.29-400.0- -3.20
2025-05-14AMRN10.17-400.0- -3.20
2025-05-15AMRN10.52-400.0- -3.20
2025-05-16AMRN10.58-400.0- -2.01
2025-05-19AMRN10.90-405.0- -2.01
2025-05-20AMRN11.08-405.0- -2.01
2025-05-21AMRN10.93-405.0- -2.01
2025-05-22AMRN11.02-405.0- -2.01
2025-05-23AMRN11.18-405.0- -2.01
2025-05-27AMRN11.36-405.0- -2.01
2025-05-28AMRN11.34-405.0- -2.01
2025-05-29AMRN11.66-405.0- -2.01
2025-05-30AMRN11.59-405.0- -2.01
2025-06-02AMRN11.76-405.0- -2.01
2025-06-03AMRN11.95-405.0- -2.01
2025-06-04AMRN11.79-405.0- -2.01
2025-06-05AMRN11.85-405.0- -2.01
2025-06-06AMRN12.73-405.0- -2.01
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-08AMRN0.0003.05
2025-05-09AMRN0.0003.05
2025-05-12AMRN0.0049.912.29
2025-05-13AMRN0.0049.912.29
2025-05-14AMRN0.0049.912.29
2025-05-15AMRN0.0049.912.29
2025-05-16AMRN0.0049.912.29
2025-05-19AMRN0.0044.942.29
2025-05-20AMRN0.0044.942.29
2025-05-21AMRN0.0044.942.29
2025-05-22AMRN0.0044.942.29
2025-05-23AMRN0.0044.942.29
2025-05-27AMRN0.00-2.512.29
2025-05-28AMRN0.00-2.512.71
2025-05-29AMRN0.00-2.512.71
2025-05-30AMRN0.00-2.512.71
2025-06-02AMRN0.001.522.71
2025-06-03AMRN0.001.522.71
2025-06-04AMRN0.001.522.71
2025-06-05AMRN0.001.522.71
2025-06-06AMRN0.001.522.71
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.04

Avg. EPS Est. Current Quarter

-0.61

Avg. EPS Est. Next Quarter

-0.7

Insider Transactions

Institutional Transactions

1.52

Beta

0.72

Average Sales Estimate Current Quarter

45

Average Sales Estimate Next Quarter

44

Fair Value

Quality Score

36

Growth Score

34

Sentiment Score

56

Actual DrawDown %

93.1

Max Drawdown 5-Year %

-95.5

Target Price

8

P/E

Forward P/E

PEG

P/S

1.23

P/B

0.56

P/Free Cash Flow

EPS

-4.27

Average EPS Est. Cur. Y​

-2.01

EPS Next Y. (Est.)

-0.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-40.99

Relative Volume

1.42

Return on Equity vs Sector %

-42.6

Return on Equity vs Industry %

-50.8

EPS 1 7Days Diff

1.2

EPS 1 30Days Diff

1.19

EBIT Estimation

Amarin Corporation plc
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 275
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.
stock quote shares AMRN – Amarin Corp ADR Stock Price stock today
news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch AMRN – Amarin Corp ADR yahoo finance google finance
stock history AMRN – Amarin Corp ADR invest stock market
stock prices AMRN premarket after hours
ticker AMRN fair value insiders trading